speb/financial-data huggingface dataset:
CATR.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 48302000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 1755000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 13827000000.00
CATR.TO income_statement (annual, 2025-12-31) — +Operating Expense: 10327000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 2815000000.00
CATR.TO income_statement (annual, 2025-12-31) — +Total Revenue: 67589000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 19133000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 8968000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8968000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 21569000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 21569000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -16766000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -16766000000.00
CATR.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 8667062893.00
CATR.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 8602520935.00
CATR.TO income_statement (annual, 2025-12-31) — Basic EPS: 1.02
CATR.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.28
CATR.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6896000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 7544000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 7761000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 7761000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -4286000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1342000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -4286000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1342000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 7181000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7181000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9980000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9980000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9980000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9980000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -2749000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -706000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3899000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 751000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4707000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1880000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 11739000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3591000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 1179000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 93000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 625000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 870000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -1477000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 538000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -176000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -38000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -294000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 61000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 1933000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 284000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Payable: 1179000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 93000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1804000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 963000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -2138000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1350000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -348000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 458000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 3133000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2462000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Commercial Paper: 5408000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Commercial Paper: 5408000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Common Stock: 7181000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 7181000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -2749000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -706000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 21318000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 21318000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -5206000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -317000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 2092000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2092000000.00
CATR.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 46111000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 13658000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8141000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8141000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Assets: 52485000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 52485000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Debt: 12634000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 12634000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 12634000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 12634000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3314000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3314000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3314000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3314000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 36558000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 36558000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Current Notes Payable: 106000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 106000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 465000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 165000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 465000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 165000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2262000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 598000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2262000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 598000000.00
CATR.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 8709476179.00
CATR.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 8648622333.00
CATR.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.02
CATR.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.28
CATR.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 8884000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2402000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 703000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 703000000.00
CATR.TO income_statement (annual, 2025-12-31) — EBIT: 12043000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — EBIT: 3153000000.00
CATR.TO income_statement (annual, 2025-12-31) — EBITDA: 14305000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — EBITDA: 3751000000.00
CATR.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 109000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 87000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -43000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -20000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 3838000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 3838000000.00
CATR.TO cash_flow (annual, 2025-12-31) — End Cash Position: 9986000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 9986000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -3899000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 751000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 8725000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 8725000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 7453000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2249000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 30000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 30000000.00
CATR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 278000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 108000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1772000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1772000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Goodwill: 5321000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 5321000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 5562000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5562000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 31906000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 31906000000.00
CATR.TO income_statement (annual, 2025-12-31) — Gross Profit: 21478000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 5475000000.00
CATR.TO income_statement (annual, 2025-12-31) — Interest Expense: 502000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 127000000.00
CATR.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 502000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 127000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Inventory: 18135000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 18135000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 64642000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 64642000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4707000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1880000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 11105000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2651000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 616000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 616000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 30690000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 30690000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 30696000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 30696000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 11105000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2651000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -8081000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1876000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 15433000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 15433000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
CATR.TO income_statement (annual, 2025-12-31) — Minority Interests: 2000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Minority Interests: 1000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 22000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 10000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -5206000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -317000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Net Debt: 33344000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 33344000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income: 8884000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income: 2402000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 8884000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2402000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 8882000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2401000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 8884000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2402000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 8884000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2402000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 8882000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2401000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 8882000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2401000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Interest Income: -502000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -127000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 517000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -111000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 4130000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1775000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 3024000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 775000000.00
CATR.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -502000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -127000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -74000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1668000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -601000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Net PPE: 15140000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 15140000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 708000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 164000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 1106000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 1000000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 15756000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 15756000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 16414000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 16414000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 2882000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 2882000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 2882000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 2882000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3838000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3838000000.00
CATR.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 14027000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 3643000000.00
CATR.TO income_statement (annual, 2025-12-31) — Normalized Income: 8672675678.02
CATR.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 2319411764.71
CATR.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 11739000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3591000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -264000000.00
CATR.TO income_statement (annual, 2025-12-31) — Operating Income: 11151000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Operating Income: 2660000000.00
CATR.TO income_statement (annual, 2025-12-31) — Operating Revenue: 67589000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 19133000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 465287332.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 465287332.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 2801000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2801000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 7120000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 7120000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2798000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2798000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1772000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1772000000.00
CATR.TO income_statement (annual, 2025-12-31) — Other Income Expense: 892000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 493000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 241000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 241000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 742000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 233000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6102000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6102000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 6175000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 6175000000.00
CATR.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 614000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 385000000.00
CATR.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 1194000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 377000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Other Properties: 6004000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 6004000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Payables: 9671000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Payables: 9671000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 17812000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 17812000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -294000000.00
CATR.TO income_statement (annual, 2025-12-31) — Pretax Income: 11541000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 3026000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CATR.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1977000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -660000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 7812000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 7812000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Receivables: 21569000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 21569000000.00
CATR.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 46111000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 13658000000.00
CATR.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2262000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 598000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -8081000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1876000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -5206000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -317000000.00
CATR.TO income_statement (annual, 2025-12-31) — Research And Development: 2148000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Research And Development: 562000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 65448000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 65448000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 22000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 10000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 2494000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 549000000.00
CATR.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 708000000.00
CATR.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 164000000.00
CATR.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 6985000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1876000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Share Issued: 814894624.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 814894624.00
CATR.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 21318000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 21318000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 15756000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 15756000000.00
CATR.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 66675678.02
CATR.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 25411764.71
CATR.TO income_statement (annual, 2025-12-31) — Tax Provision: 2768000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 712000000.00
CATR.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CATR.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
CATR.TO balance_sheet (annual, 2025-12-31) — Total Assets: 98585000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 98585000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 52008000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 52008000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Debt: 43330000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 43330000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 21318000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 21318000000.00
CATR.TO income_statement (annual, 2025-12-31) — Total Expenses: 56438000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 16473000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 77267000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 77267000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 46100000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 46100000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 40709000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 40709000000.00
CATR.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 11151000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2660000000.00
CATR.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 278000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 108000000.00
CATR.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 278000000.00
CATR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 108000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 349607292.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 349607292.00
CATR.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 49539000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 49539000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Work In Process: 1598000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 1598000000.00
CATR.TO balance_sheet (annual, 2025-12-31) — Working Capital: 15927000000.00
CATR.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 15927000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 2679000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 17415000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9641000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 21890000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8545355201.00
CATR.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.30
CATR.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 9986000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1051000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1051000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 5852000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4072000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4072000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -703000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5950000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1775000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1870000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 938000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1325000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1501000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -184000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -330000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1328000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 938000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -387000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -801000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1875000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5855000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 5852000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -703000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 18661000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -5125000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11651000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 6888000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 48568000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 12424000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12424000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 4382000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 4382000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 35902000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 534000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 534000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 595000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 595000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8589612544.00
CATR.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.30
CATR.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2549000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 0.00
CATR.TO income_statement (quarterly, 2026-03-31) — EBIT: 3345000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — EBITDA: 3940000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 7000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -55000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 3659000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 4076000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5950000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 9179000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 819000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 137000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1881000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 5865000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6284000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 5764000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 134000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 134000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 19626000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 61727000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1775000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3908000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 30642000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30642000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 3908000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -3222000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: -1000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Minority Interests: 1000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -5125000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 38994000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income: 2549000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2549000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2548000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2549000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2549000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2548000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2548000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -134000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -894000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -122000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 686000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -134000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -21000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 15249000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 191000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -808000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 12377000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 16831000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2419000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2419000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3659000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3803000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 2440586110.25
CATR.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1870000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Operating Income: 3085000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 17415000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 460637026.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2980000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 12424000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2567000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1881000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 260000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 419000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 68000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6199000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 6687000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 123000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 326000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Payables: 9641000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 16529000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 3211000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1255000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 8447000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 21890000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11651000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 595000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -3222000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -5125000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Research And Development: 537000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 67997000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 361000000.00
CATR.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 191000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1816000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 814894624.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 18661000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 12377000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 28586110.25
CATR.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 670000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 95550000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 49303000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 43066000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 18660000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 14330000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 76890000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 46982000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 40988000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 3085000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 137000000.00
CATR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 137000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 354257598.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 53307000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 2000000000.00
CATR.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 12666000000.00
CATX cash_flow (annual, 2021-06-30) — Amortization Cash Flow: 37000.00
CATX cash_flow (annual, 2021-06-30) — Amortization Of Intangibles: 37000.00
CATX cash_flow (annual, 2021-06-30) — Cash Dividends Paid: -9000.00
CATX cash_flow (annual, 2021-06-30) — Changes In Account Receivables: 31000.00
CATX income_statement (annual, 2021-06-30) — Cost Of Revenue: 4932000.00
CATX balance_sheet (annual, 2021-06-30) — Current Accrued Expenses: 560000.00
CATX balance_sheet (annual, 2021-06-30) — Finished Goods: 49000.00
CATX income_statement (annual, 2021-06-30) — Gross Profit: 5121000.00
CATX balance_sheet (annual, 2021-06-30) — Inventory: 980000.00
CATX balance_sheet (annual, 2021-06-30) — Long Term Provisions: 608000.00
CATX balance_sheet (annual, 2021-06-30) — Non Current Accrued Expenses: 77000.00
CATX balance_sheet (annual, 2021-06-30) — Notes Receivable: 0.00
CATX cash_flow (annual, 2021-06-30) — Operating Gains Losses: 10000.00
CATX income_statement (annual, 2021-06-30) — Other Income Expense: -9000.00
CATX balance_sheet (annual, 2021-06-30) — Other Non Current Assets: 258000.00
CATX cash_flow (annual, 2021-06-30) — Preferred Stock Dividend Paid: -9000.00
CATX income_statement (annual, 2021-06-30) — Preferred Stock Dividends: 3000.00
CATX balance_sheet (annual, 2021-06-30) — Raw Materials: 645000.00
CATX income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 4932000.00
CATX income_statement (annual, 2021-06-30) — Salaries And Wages: 252000.00
CATX income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 2391000.00
CATX balance_sheet (annual, 2021-06-30) — Treasury Stock: 0.00
CATX balance_sheet (annual, 2021-06-30) — Work In Process: 286000.00
CATX income_statement (annual, 2022-06-30) — +Operating Expense: 12007000.00
CATX income_statement (annual, 2022-06-30) — +Total Revenue: 10795000.00
CATX balance_sheet (annual, 2022-06-30) — Accounts Payable: 966000.00
CATX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 1608000.00
CATX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -7496000.00
CATX balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 159732000.00
CATX balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -26000.00
CATX cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 41000.00
CATX cash_flow (annual, 2022-06-30) — Amortization Of Intangibles: 41000.00
CATX income_statement (annual, 2022-06-30) — Basic Average Shares: 14198700.00
CATX income_statement (annual, 2022-06-30) — Basic EPS: -0.50
CATX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 64010000.00
CATX cash_flow (annual, 2022-06-30) — Capital Expenditure: -266000.00
CATX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 524000.00
CATX balance_sheet (annual, 2022-06-30) — Capital Stock: 142000.00
CATX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 55890000.00
CATX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 55890000.00
CATX cash_flow (annual, 2022-06-30) — Cash Dividends Paid: 0.00
CATX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 56000.00
CATX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -284000.00
CATX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -7710000.00
CATX cash_flow (annual, 2022-06-30) — Change In Account Payable: 236000.00
CATX cash_flow (annual, 2022-06-30) — Change In Accrued Expense: 136000.00
CATX cash_flow (annual, 2022-06-30) — Change In Inventory: -2673000.00
CATX cash_flow (annual, 2022-06-30) — Change In Payable: 236000.00
CATX cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 372000.00
CATX cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: 46000.00
CATX cash_flow (annual, 2022-06-30) — Change In Receivables: 405000.00
CATX cash_flow (annual, 2022-06-30) — Change In Working Capital: -1850000.00
CATX cash_flow (annual, 2022-06-30) — Changes In Cash: -7938000.00
CATX balance_sheet (annual, 2022-06-30) — Common Stock: 142000.00
CATX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 61277000.00
CATX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 0.00
CATX income_statement (annual, 2022-06-30) — Cost Of Revenue: 6179000.00
CATX balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 779000.00
CATX balance_sheet (annual, 2022-06-30) — Current Assets: 59329000.00
CATX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 268000.00
CATX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 268000.00
CATX balance_sheet (annual, 2022-06-30) — Current Liabilities: 2266000.00
CATX cash_flow (annual, 2022-06-30) — Depreciation: 248000.00
CATX cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 248000.00
CATX cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 248000.00
CATX income_statement (annual, 2022-06-30) — Diluted Average Shares: 14198700.00
CATX income_statement (annual, 2022-06-30) — Diluted EPS: -0.50
CATX income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -7272000.00
CATX income_statement (annual, 2022-06-30) — EBIT: -7391000.00
CATX income_statement (annual, 2022-06-30) — EBITDA: -7143000.00
CATX cash_flow (annual, 2022-06-30) — End Cash Position: 56072000.00
CATX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 56000.00
CATX balance_sheet (annual, 2022-06-30) — Finished Goods: 23000.00
CATX cash_flow (annual, 2022-06-30) — Free Cash Flow: -7976000.00
CATX cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of PPE: 0.00
CATX income_statement (annual, 2022-06-30) — Gain On Sale Of Ppe: 0.00
CATX income_statement (annual, 2022-06-30) — General And Administrative Expense: 6668000.00
CATX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 107000.00
CATX balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 1634000.00
CATX balance_sheet (annual, 2022-06-30) — Gross PPE: 9984000.00
CATX income_statement (annual, 2022-06-30) — Gross Profit: 4616000.00
CATX income_statement (annual, 2022-06-30) — Interest Income: 119000.00
CATX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 119000.00
CATX balance_sheet (annual, 2022-06-30) — Inventory: 1396000.00
CATX balance_sheet (annual, 2022-06-30) — Invested Capital: 61277000.00
CATX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -284000.00
CATX balance_sheet (annual, 2022-06-30) — Investments And Advances: 0.00
CATX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 0.00
CATX balance_sheet (annual, 2022-06-30) — Land And Improvements: 366000.00
CATX balance_sheet (annual, 2022-06-30) — Leases: 4143000.00
CATX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 256000.00
CATX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 256000.00
CATX balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 0.00
CATX balance_sheet (annual, 2022-06-30) — Long Term Provisions: 640000.00
CATX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 0.00
CATX income_statement (annual, 2022-06-30) — Net Income: -7272000.00
CATX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -7272000.00
CATX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -7272000.00